tradingkey.logo
tradingkey.logo
検索

Charles River Laboratories International Inc

CRL
ウォッチリストに追加
278.260USD
+5.260+1.93%
終値 09-11 16:00ET
13.28B時価総額
損失額直近12ヶ月PER
時間外取引 19:00 (ET)278.260USD+0.300+0.11%

詳細情報 Charles River Laboratories International Inc 企業名

Charles River Laboratories International, Inc. is a drug development company. It provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Its Research Models and Services segment includes three businesses that provide foundational tools that enable its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.

Charles River Laboratories International Inc プロフィール

企業コードCRL
会社名Charles River Laboratories International Inc
上場日Jun 23, 2000
最高経営責任者「CEO」Foster (James C)
従業員数18600
証券種類Ordinary Share
決算期末Jun 23
本社所在地251 Ballardvale St
都市WILMINGTON
証券取引所NASDAQ OMX NASDAQ Basic NYSE
United States of America
郵便番号01887
電話番号17812226000
ウェブサイトhttps://www.criver.com/
企業コードCRL
上場日Jun 23, 2000
最高経営責任者「CEO」Foster (James C)

Charles River Laboratories International Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Ms. Birgit Girshick
Ms. Birgit Girshick
Chief Executive Officer
Chief Executive Officer
58.26K
-0.91%
Mr. Glenn G. Coleman
Mr. Glenn G. Coleman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
27.75K
--
Mr. James C. Foster
Mr. James C. Foster
Non-Executive Director
Non-Executive Director
26.98K
--
Ms. Victoria L. (Vicky) Creamer
Ms. Victoria L. (Vicky) Creamer
Corporate Executive Vice President, Chief People Officer
Corporate Executive Vice President, Chief People Officer
20.94K
--
Mr. Joseph W. LaPlume
Mr. Joseph W. LaPlume
Corporate Executive Vice President - Corporate Development and Strategy
Corporate Executive Vice President - Corporate Development and Strategy
14.47K
-1.78%
Ms. Virginia M. (Gina) Wilson, CPA
Ms. Virginia M. (Gina) Wilson, CPA
Independent Director
Independent Director
6.35K
+22.65%
Ms. Shannon M. Parisotto
Ms. Shannon M. Parisotto
Corporate Executive Vice President - Discovery and Safety Assessment Management
Corporate Executive Vice President - Discovery and Safety Assessment Management
5.67K
-88.92%
Ms. Reshema Kemps-Polanco
Ms. Reshema Kemps-Polanco
Independent Director
Independent Director
4.56K
+43.24%
Dr. Craig B. Thompson, M.D.
Dr. Craig B. Thompson, M.D.
Independent Director
Independent Director
3.85K
+37.34%
Mr. Abraham N. (Abe) Ceesay
Mr. Abraham N. (Abe) Ceesay
Independent Director
Independent Director
2.38K
+60.32%
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Ms. Birgit Girshick
Ms. Birgit Girshick
Chief Executive Officer
Chief Executive Officer
58.26K
-0.91%
Mr. Glenn G. Coleman
Mr. Glenn G. Coleman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
27.75K
--
Mr. James C. Foster
Mr. James C. Foster
Non-Executive Director
Non-Executive Director
26.98K
--
Ms. Victoria L. (Vicky) Creamer
Ms. Victoria L. (Vicky) Creamer
Corporate Executive Vice President, Chief People Officer
Corporate Executive Vice President, Chief People Officer
20.94K
--
Mr. Joseph W. LaPlume
Mr. Joseph W. LaPlume
Corporate Executive Vice President - Corporate Development and Strategy
Corporate Executive Vice President - Corporate Development and Strategy
14.47K
-1.78%
Ms. Virginia M. (Gina) Wilson, CPA
Ms. Virginia M. (Gina) Wilson, CPA
Independent Director
Independent Director
6.35K
+22.65%

よくある質問

Charles River Laboratories International Incの上位5名の株主は誰ですか?

Charles River Laboratories International Incの上位5名の株主は以下のとおりです。Ms. Birgit Girshick

Charles River Laboratories International Inc(CRL)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Charles River Laboratories International Incの株式を保有している機関は1429社あり、保有株式の総市場価値は約56.13Mで、全体の116.51%を占めています。2025Q4と比較して、機関の持ち株は-7963916.00増加しています。

Charles River Laboratories International Incの最大の収益源は何ですか?

2026Q1において、DSA部門がCharles River Laboratories International Incにとって最大の収益を生み出しており、その金額は606.51Mで、全収益の60.40%を占めています。
tradingkey.logo
リスク告知:当社ウェブサイト及びモバイルアプリは特定の投資商品に関する一般的な情報のみを提供しており、Finsightsは金融アドバイスや投資商品の推奨を行うものではありません。本情報の提供をもってFinsightsが投資助言を行っていると解釈されることはありません。
投資商品には元本割れを含む重大なリスクが伴い、全ての投資家に適するものではありません。なお、過去の運用実績は将来の成果を保証するものではありません。
Finsightsは、第三者広告主または提携先が当社ウェブサイト・モバイルアプリ上に広告を掲載することを許可する場合があり、これら広告主から広告への反応に基づく報酬を受けることがあります。
© 著作権: FINSIGHTS MEDIA PTE. LTD. 無断複写・転載を禁じます。